REGEN BIOPHARMA, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 69.3% | 69.3% | -558.1% |
| FY2022 | -50.0% | -50.0% | 437.1% |
| FY2023 | -22.7% | -22.7% | 327.1% |
| FY2024 | 12.8% | 12.8% | -414.8% |
| FY2025 | 20.3% | 20.3% | -464.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 69.3% | 69.3% | -558.1% |
| FY2022 | -50.0% | -50.0% | 437.1% |
| FY2023 | -22.7% | -22.7% | 327.1% |
| FY2024 | 12.8% | 12.8% | -414.8% |
| FY2025 | 20.3% | 20.3% | -464.1% |